Viewing Study NCT01593527

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-06-05 @ 8:40 AM
Study NCT ID: NCT01593527
Status: WITHDRAWN
Last Update Posted: 2017-04-20
First Post: 2012-05-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Gouty Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Frequent flares View
None Frequent attacks View
None gout View
None gouty arthritis View
None Chronic kidney disease View
None renal impairment View
None Anti-interleukin-1β monoclonal antibody View
None anti-inflammatory therapy View